Search research articles
Contact Us
Filters
Showing results (631-640 of 754) with videos related to
Page
of 76
Sort By:
European Journal of Heart Failure
|
July 26, 2024
Acute changes in kidney function and outcomes following an acute myocardial infarction: Insights from PARADISE-MI
Finnian R Mc Causland, Martina M McGrath, Brian L Claggett, et al.
American Journal of Nephrology
|
July 12, 2018
Serum Calcification Propensity and Fetuin-A: Biomarkers of Cardiovascular Disease in Kidney Transplant Recipients
Andrew Bostom, Andreas Pasch, Tracy Madsen, et al.
Heart (British Cardiac Society)
|
April 30, 2017
Streamlining cardiovascular clinical trials to improve efficiency and generalisability
Faiez Zannad, Marc A Pfeffer, Deepak L Bhatt, et al.
Circulation
|
February 16, 2006
Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program
Eileen O'Meara, Tim Clayton, Margaret B McEntegart, et al.
European Heart Journal
|
August 17, 1999
Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry
B A Bart, G Ertl, P Held, et al.
European Journal of Preventive Cardiology
|
October 15, 2025
Future myocardial infarction after an acute coronary syndrome and pharmacogenetic response to dalcetrapib
Jean-Claude Tardif, Marc A Pfeffer, Simon Kouz, et al.
Circulation
|
July 28, 2010
Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both
Anne-Catherine Pouleur, Ebrahim Barkoudah, Hajime Uno, et al.
Circulation. Heart Failure
|
May 1, 2023
Prognostic Importance of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Following High-Risk Myocardial Infarction in the PARADISE-MI Trial
Karola S Jering, Brian L Claggett, Marc A Pfeffer, et al.
Journal of Diabetes Research
|
January 17, 2019
Retinopathy, Neuropathy, and Subsequent Cardiovascular Events in Patients with Type 2 Diabetes and Acute Coronary Syndrome in the ELIXA: The Importance of Disease Duration
Jelena P Seferovic, Rhonda Bentley-Lewis, Brian Claggett, et al.
European Journal of Heart Failure
|
November 17, 2022
Health-related quality of life outcomes in PARAGON-HF
Alvin Chandra, Carisi A Polanczyk, Brian L Claggett, et al.
Page
of 76
Search research articles
Search
Showing results (631-640 of 754) with videos related to
Sort By:
Page
of 76
European Journal of Heart Failure
|
July 26, 2024
Acute changes in kidney function and outcomes following an acute myocardial infarction: Insights from PARADISE-MI
Finnian R Mc Causland, Martina M McGrath, Brian L Claggett, et al.
American Journal of Nephrology
|
July 12, 2018
Serum Calcification Propensity and Fetuin-A: Biomarkers of Cardiovascular Disease in Kidney Transplant Recipients
Andrew Bostom, Andreas Pasch, Tracy Madsen, et al.
Heart (British Cardiac Society)
|
April 30, 2017
Streamlining cardiovascular clinical trials to improve efficiency and generalisability
Faiez Zannad, Marc A Pfeffer, Deepak L Bhatt, et al.
Circulation
|
February 16, 2006
Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program
Eileen O'Meara, Tim Clayton, Margaret B McEntegart, et al.
European Heart Journal
|
August 17, 1999
Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry
B A Bart, G Ertl, P Held, et al.
European Journal of Preventive Cardiology
|
October 15, 2025
Future myocardial infarction after an acute coronary syndrome and pharmacogenetic response to dalcetrapib
Jean-Claude Tardif, Marc A Pfeffer, Simon Kouz, et al.
Circulation
|
July 28, 2010
Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both
Anne-Catherine Pouleur, Ebrahim Barkoudah, Hajime Uno, et al.
Circulation. Heart Failure
|
May 1, 2023
Prognostic Importance of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Following High-Risk Myocardial Infarction in the PARADISE-MI Trial
Karola S Jering, Brian L Claggett, Marc A Pfeffer, et al.
Journal of Diabetes Research
|
January 17, 2019
Retinopathy, Neuropathy, and Subsequent Cardiovascular Events in Patients with Type 2 Diabetes and Acute Coronary Syndrome in the ELIXA: The Importance of Disease Duration
Jelena P Seferovic, Rhonda Bentley-Lewis, Brian Claggett, et al.
European Journal of Heart Failure
|
November 17, 2022
Health-related quality of life outcomes in PARAGON-HF
Alvin Chandra, Carisi A Polanczyk, Brian L Claggett, et al.
Page
of 76